ORASURE TECHNOLOGIES, INC Debt Securities, Available-for-sale
ORASURE TECHNOLOGIES, INC (OSUR) had Debt Securities, Available-for-sale of $0 as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-03-09
- 2025-12-31: Debt Securities, Available-for-sale $0.00.
- 2025-09-30: Debt Securities, Available-for-sale $0.00.
- 2025-06-30: Debt Securities, Available-for-sale $0.00.
- 2025-03-31: Debt Securities, Available-for-sale $0.00.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-09 |
| 2024-06-30 | $9.14M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $16.63M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $0.00 10-Q · filed 2024-11-06 |
| 2023-09-30 | $7.36M 10-Q · filed 2023-11-08 |
| 2023-03-31 | $22.18M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $26.87M 10-K · filed 2024-03-11 |
| 2022-09-30 | $26.43M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $29.63M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $41.50M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $53.29M 10-K · filed 2023-03-03 |
| 2020-12-31 | $96.32M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |